This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

News

PCI Builds North American Clinical Sales Team

PCI Clinical Services have expanded our North American Clinical sales team with the appointment of Nadine DuChateau as Business Development Executive.

Following an extensive career in clinical development services with more than 15 years’ experience in the field, Nadine joins the PCI team to support the development of the company’s client base in the Midwest. Prior to PCI, Nadine spent two years at a leading contract development and manufacturing organization in the pharmaceutical and biotechnology sector.

Nadine-DuChateau

At PCI, Nadine will be responsible for account management and territory growth for our global clinical packaging and logistics services in the Midwest, maintaining and growing market share with key customers while developing new business and cross-selling PCI’s high potency oral solid manufacturing, commercial packaging and analytical testing services.

Welcoming Nadine to PCI, Tim Roberts, PCI North America Business Development Director, commented: “We are thrilled Nadine will be part of our team. She brings a wealth of experience and has a glowing record of accomplishments that she’s achieved over her career. We are looking forward to working with her here at PCI Clinical Services and her insightful contributions to the success of our clients.

Nadine said: “I am excited for this new opportunity given PCI’s reputation as the market leader. I’m really looking forward to joining the team and leveraging my experience in my new role to deliver great results for both new and current clients.

August 30, 2017


Webflow Mobile App Launch

PCI Is pleased to announce the launch of a mobile application to provide more convenient access to its client services... View Article

PCI Announces Further Investment in Fully Contained Xcelodose® 600S Technology Delivering Excellence in Clinical Services

PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center... View Article

x